NPM1 and acute myeloid leukemia: The cluster1 AML patients showed younger age, lower cytogenetics risk, higher frequency of NPM1 mutations and better OS than cluster3 patients (P values < 0.05 for all cases, Wilcoxon sum rank test, fisher exact test or log-rank test, Fig. 4 and Additional file 2: Table 6).